Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.48 |
| ▸ | CTSC | P53634 | 3/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | PRCP | P42785 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19180219 | 1.00 | MEN1 (0.51) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL21194967 | 1.00 | MEN1 (0.51) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL1604372 | 1.00 | MEN1 (0.51) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL29376508 | 0.95 | MEN1 (0.47) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL29352279 | 0.89 | FOLH1 (0.47) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL29608142 | 0.89 | MEN1 (0.44) | MEN1KMT2AFOLH1RIMKLANAALAD2 | |
| SCHEMBL21647349 | 0.89 | KMT2A (0.49) | MEN1KMT2ADPP7CTSCPRCP | |
| SCHEMBL5970810 | 0.89 | KMT2A (0.49) | MEN1KMT2ADPP7CTSCPRCP | |
| SCHEMBL5970814 | 0.89 | KMT2A (0.49) | MEN1KMT2ADPP7CTSCPRCP | |
| SCHEMBL30193508 | 0.88 | MEN1 (0.45) | MEN1KMT2AFOLH1RIMKLANAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| US-20250296971-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-09-25 | — | — | US | claimed |
| US-12317911-B2 | Flavor compositions and screening methods for identifying the same | MARS, INCORPORATED (US) | 2025-06-03 | — | — | US | claimed |
| CN-119530123-A | Low-sodium salt-reducing and freshness-increasing metaplasia and preparation method and application thereof | 内蒙古科拓生物有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118501300-B | Method for detecting total content of proline or hydroxyproline dipeptide in collagen peptide | 中国海洋大学三亚海洋研究院 | 2024-10-11 | — | — | CN | claimed |
| CN-118725196-A | Dual-functional polymer material, preparation method and application thereof in proteomics analysis | 宁波市第二医院 | 2024-10-01 | — | — | CN | claimed |
| US-20240315296-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ CHEILJEDANG CORPORATION (KR) | 2024-09-26 | — | — | US | claimed |
| CN-118632858-A | Gastric inhibitory peptide receptor ligands | 3B制药有限公司 | 2024-09-10 | — | — | CN | claimed |
| EP-4423110-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2024-09-04 | — | — | EP | claimed |
| US-20230136613-A1 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING INFECTIONS | San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation | 2023-05-04 | — | — | US | claimed |
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | claimed |
| WO-2023277549-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | 씨제이제일제당 (주) | 2023-01-05 | — | — | WO | claimed |
| WO-2022181712-A1 | COMPOSITION CONTAINING DECOMPOSED PRODUCTS OF VEGETABLE PROTEIN AND METHOD FOR PRODUCING SAME | 株式会社Mizkan Holdings | 2022-09-01 | — | — | WO | claimed |
| CN-114605522-A | MCL-1 and BCL-XL protein dual-targeting BH3 polypeptide mimics and application thereof | 中山大学 | 2022-06-10 | — | — | CN | claimed |
| US-11028386-B2 | Morpholino oligonucleotide manufacturing method | AJINOMOTO CO., INC. (JP) | 2021-06-08 | — | — | US | claimed |
| CN-106795186-B | Process for preparing morpholino oligonucleotides | 味之素株式会社 | 2021-03-02 | — | — | CN | claimed |
| US-20200040331-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2020-02-06 | — | — | US | claimed |
| EP-3208277-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2017-08-23 | — | — | EP | claimed |
| US-20170218361-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | AJINOMOTO CO., INC. (JP) | 2017-08-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296971-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | GIPR, VIP, GRPR | MEN1 1139/4885KMT2A 3863/4885FOLH1 661/4885 |
| US-20200040331-A1 | MORPHOLINO OLIGONUCLEOTIDE MANUFACTURING METHOD | DCLRE1B, RNGTT, RTCB | MEN1 1767/4885KMT2A 1980/4885FOLH1 3138/4885 |
| US-11028386-B2 | Morpholino oligonucleotide manufacturing method | DCLRE1B, RNGTT, RTCB | MEN1 1767/4885KMT2A 1980/4885FOLH1 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.